Preview

Pharmaceutical Excipients Market worth $7,356.2 Million by 2018

Satisfactory Essays
Open Document
Open Document
386 Words
Grammar
Grammar
Plagiarism
Plagiarism
Writing
Writing
Score
Score
Pharmaceutical Excipients Market worth $7,356.2 Million by 2018
The "Pharmaceutical Excipients Market [By Products (Carbohydrates, Oleochemicals, Petrochemicals, Polymers, Microcrystalline Cellulose, Sugar, Calcium carbonate), By Functionality (Fillers, Binders, Lubricants, Preservatives)] – Global Forecast to 2018 " analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia-Pacific, and the Rest of the World.
Browse 112 market data tables with 48 figures spread through 315 pages and in-depth TOC on "Pharmaceutical Excipients Market [By Products (Carbohydrates, Oleochemicals, Petrochemicals, Polymers, Microcrystalline Cellulose, Sugar, Calcium carbonate), By Functionality (Fillers, Binders, Lubricants, Preservatives)] – Global Forecast to 2018". http://www.marketsandmarkets.com/Market-Reports/pharma-excipients-market-956.html Early buyers will receive 10% customization on reports.
This report studies the global pharmaceutical excipients market, with forecast to 2018.
The pharmaceutical excipients market has experienced extensive growth in the past few years, mainly attributed to the various advancements in the pharmaceutical industry related to drug delivery technologies. The increasing use of generics and the emergence of new excipients are factors that further propel the growth of this market. However, the increasing cost of raw materials, stringent regulatory requirements and quality specifications, and the increasingly competitive environment are factors that inhibit the growth of the market to a certain extent.
China, India, and Japan are likely to drive the growth of the Asian market. A majority of the growth in these markets is driven by increase in outsourcing to these locations mainly due to low-labor costs. These are also some of the most lucrative markets for manufacturing of generic drugs for the global market.
The major players in the pharmaceutical excipients market include Ashland, Inc. (U.S.), BASF (Germany), Dow Chemical Company (U.S.), Roquette

You May Also Find These Documents Helpful

  • Best Essays

    Ldr 531 Week 5

    • 2421 Words
    • 10 Pages

    Plunkett, J. W. (August 19, 2010). Domestic & Foreign Pharmaceutical Sales, PhRMA Member Companies: 1975-2009. [Electronic version]. Biotechnology, Drugs & Genetics Industry. Retrieved October 24, 2010 from http://www.plunkettresearchonline.com…

    • 2421 Words
    • 10 Pages
    Best Essays
  • Good Essays

    The Pharmaceutical industry has several high entry barriers as shown in figure 1. Economies of scale, product differentiation, government policy and capital requirements and financial services are few barriers for new entrant. Level of threat from rivalry is also high in this industry. Industry has presence of large number of small firms of a similar size. They are in direct competition with one another,…

    • 1056 Words
    • 5 Pages
    Good Essays
  • Powerful Essays

    The pharmaceutical market in general is consisting of many stockholders and it consist of many layers…

    • 2327 Words
    • 10 Pages
    Powerful Essays
  • Powerful Essays

    Vyvanse Global Marketing Plan

    • 14341 Words
    • 58 Pages

    Vyvanse, incorporated with Shire Corporation, is a central nervous system stimulant made for children and adults with attention deficit hyperactive disorder (ADHD). The drug is meant to improve focus, organization, and to ease impulsivity in both children and adults.…

    • 14341 Words
    • 58 Pages
    Powerful Essays
  • Satisfactory Essays

    The report titled “The US Anti Cancer Drug Market Outlook to 2018 - Demand of Oral Drugs to Drive Growth” provides a comprehensive analysis on the Anti Cancer Drug market in the US covering various aspects such as market size of the industry, market segmentation by Patented and Generic drugs, by type of cancer (blood cancer, breast cancer, lung cancer, pancreatic cancer, colon cancer) and by Oral and Injectable Drugs. The report also provides statistics and information on the government regulations, growth drivers and market shares of major players and brands in the market. The report also entails competitive landscape and profiles of the major players operating in the market. The future projections are included to provide an insight on the prospects in the US Anti Cancer Drug Market.…

    • 608 Words
    • 2 Pages
    Satisfactory Essays
  • Good Essays

    * Pfizer: Pharmaceutical companies have low pressures for local responsiveness as their products serve universalistic needs. Cost pressures on the other hand are intense therefore the most appropriate strategy is a Global one.…

    • 670 Words
    • 3 Pages
    Good Essays
  • Satisfactory Essays

    5 Porter Analysis

    • 1705 Words
    • 7 Pages

    The specialty chemicals market will be analyzed taking specialty chemicals manufacturers as players. The key buyers…

    • 1705 Words
    • 7 Pages
    Satisfactory Essays
  • Powerful Essays

    Sanofi-Aventis Acquisition

    • 5913 Words
    • 19 Pages

    In the year 2004, the global economy experienced a momentum. After the dot.com bubble and the 9/11 terrorist attacks, the economy slowed down, especially in the USA. The American economy, which was the greatest market for the pharmaceutical industry, suffered an economic recession from 2001 to 2003. However, in 2004 the tax cuts and the lower interest rates stimulated a robust expansion in that country.…

    • 5913 Words
    • 19 Pages
    Powerful Essays
  • Better Essays

    From the cases and readings this week, it is clear that perhaps the largest missteps for both Pfizer and Eli Lilly were their failures to understand the changing basis of competition. Christensen states that "when multiple products offer enough functionality and enough reliability, then customers will be reluctant to pay price premiums for improvements in either of these areas" (Christensen, 1999). In Eli Lilly’s (Eli’s) roll out of synthetic insulin and in their future plans for the roll out of a long-release insulin product, they have clearly failed to recognize this concept. They 're not likely to gain premium pricing for either of these as they represent very little improvement to the client.…

    • 1145 Words
    • 5 Pages
    Better Essays
  • Powerful Essays

    Pfizer-Wyeth M&a Analysis

    • 8332 Words
    • 34 Pages

    On January 25, 2009, Pfizer and Wyeth entered into the merger agreement, pursuant to which, subject to the terms and conditions set forth in the merger agreement, Wyeth will become a wholly-owned subsidiary of Pfizer. Upon completion of the merger, each share of Wyeth common stock issued and outstanding will be converted into the right to…

    • 8332 Words
    • 34 Pages
    Powerful Essays
  • Powerful Essays

    Information asymmetry or imbalance is one of the prime reasons of market failure in pharmaceutical sector. For different commodities such as vegetables, fruits and others, both buyers and sellers are equally aware about its value for money and quality. But in case of pharmaceutical drugs, one party tends to know much more than the other and most often it’s the end consumers that suffer. This becomes one of the main reasons for market failure in this sector…

    • 2168 Words
    • 9 Pages
    Powerful Essays
  • Powerful Essays

    Vlueco

    • 3159 Words
    • 13 Pages

    References: The Nutritional Business Journal – Market data projections for the nutritional supplements Industry can be found in the following article : http://newhope360.com/supplements/infographic-highlights-2013-supplement-business-report…

    • 3159 Words
    • 13 Pages
    Powerful Essays
  • Good Essays

    The CIS market for insulin and insulin products is expected to reach USD 3,008.5 million by 2020 growing at a CAGR of 15.0%, according to a new study by Grand View Research, Inc. The presence of an extensive pipeline portfolio of products exhibiting higher efficacies and their subsequent commercialization over the next six years is expected to serve this market as a high impact rendering driver. The introduction of government initiatives aimed at improving the affordability of insulin via price reduction, such as the collaboration between the government of Ukraine and Indar to reduce the price of insulin by 20% in 2013 is expected to have positive influence on demand. Some of the other drivers of this market include increasing attempts made by manufacturers to capitalize on the untapped opportunities by opening new manufacturing units to improve the supply of insulin and growing incidence rates of type II diabetes are some of the factors expected to fuel future market growth.…

    • 599 Words
    • 3 Pages
    Good Essays
  • Satisfactory Essays

    over 20 therapy areas and nearly 3,000 indications. The report is built using data and…

    • 1741 Words
    • 10 Pages
    Satisfactory Essays
  • Powerful Essays

    Business Lines :: Manufacturing and marketing of pharmaceutical Finished Formulation Products, Large Volume Parenterals and Active Pharmaceutical Ingredients (APIs)…

    • 3482 Words
    • 14 Pages
    Powerful Essays